Glutaral


Generic Medicine Info
Indications and Dosage
Topical/Cutaneous
Wart removal
Adult: As a 10% soln: Apply onto affected areas bid.
Child: Same as adult dose.
Contraindications
Application to face and anogenital region, broken skin, and moles.
Adverse Reactions
Significant: Mild to severe eye and skin irritation.
Resp: Occupational asthma, resp (e.g. nose, throat, lungs) irritation.
Dermatologic: Brown staining of skin, allergic contact dermatitis and skin sensitisation.
Patient Counseling Information
Avoid contact w/ eyes and mucous membranes.
Action
Description: Glutaral is an aldehyde used as a disinfectant. It is effective against gm+ve and gm-ve bacteria, some fungi, and viruses including hepatitis B virus and HIV. It also has anhidrotic effect, drying the warts and the surrounding skin, thereby reducing the spread of lesions and facilitating easier removal of persistent warts.
Storage
Store below 25°C. Keep away from flame. Store upright.
References
Buckingham R (ed). Glutaral. Martindale: The Complete Drug Reference [online]. London. Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 05/06/2017.

Glutarol 10% w/v Cutaneous Solution (Diomed Developments Limited). MHRA. https://products.mhra.gov.uk/. Accessed 05/06/2017.

Joint Formulary Committee. Glutaraldehyde. British National Formulary [online]. London. BMJ Group and Pharmaceutical Press. https://www.medicinescomplete.com. Accessed 05/06/2017.

Disclaimer: This information is independently developed by MIMS based on Glutaral from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 MIMS. All rights reserved. Powered by MIMS.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in